CDKN2A and liver cancer: P16ink4a is found hypermethylated in numerous types of tumors including 27% of colorectal cancer with a sensitivity of 70%, and a specificity of 100% from patient serum in liver cancer with a sensitivity of 73%, and in 24% of lung cancer [72–75].